The limitations and hidden gems of the epidemiology of primary biliary cirrhosis

Mauro Podda, Carlo Selmi, Ana Lleo, Luca Moroni, Pietro Invernizzi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1%, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools.

Original languageEnglish (US)
Pages (from-to)81-87
Number of pages7
JournalJournal of Autoimmunity
Volume46
DOIs
StatePublished - Oct 2013

Fingerprint

Biliary Liver Cirrhosis
Epidemiology
Serum
Population
Asymptomatic Diseases
Death Certificates
Data Mining
Monozygotic Twins
Liver Transplantation
Delivery of Health Care
Incidence

Keywords

  • Clinical epidemiology
  • Primary biliary cirrhosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. / Podda, Mauro; Selmi, Carlo; Lleo, Ana; Moroni, Luca; Invernizzi, Pietro.

In: Journal of Autoimmunity, Vol. 46, 10.2013, p. 81-87.

Research output: Contribution to journalArticle

Podda, Mauro ; Selmi, Carlo ; Lleo, Ana ; Moroni, Luca ; Invernizzi, Pietro. / The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. In: Journal of Autoimmunity. 2013 ; Vol. 46. pp. 81-87.
@article{3e5265403ed944bfa6b8d774311c62fb,
title = "The limitations and hidden gems of the epidemiology of primary biliary cirrhosis",
abstract = "Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1{\%}, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools.",
keywords = "Clinical epidemiology, Primary biliary cirrhosis",
author = "Mauro Podda and Carlo Selmi and Ana Lleo and Luca Moroni and Pietro Invernizzi",
year = "2013",
month = "10",
doi = "10.1016/j.jaut.2013.06.015",
language = "English (US)",
volume = "46",
pages = "81--87",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The limitations and hidden gems of the epidemiology of primary biliary cirrhosis

AU - Podda, Mauro

AU - Selmi, Carlo

AU - Lleo, Ana

AU - Moroni, Luca

AU - Invernizzi, Pietro

PY - 2013/10

Y1 - 2013/10

N2 - Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1%, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools.

AB - Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1%, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools.

KW - Clinical epidemiology

KW - Primary biliary cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=84886287502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886287502&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2013.06.015

DO - 10.1016/j.jaut.2013.06.015

M3 - Article

C2 - 23871640

AN - SCOPUS:84886287502

VL - 46

SP - 81

EP - 87

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

ER -